Thursday’s insider buys and sells: CEOs add shares, executives cash out

Conagra CEO John P. Brase bought 35,000 shares on July 17, 2026, disclosed via Form 4 on July 21.

Limited near-term impact; any effect is likely sentiment-driven and short-lived.

The article provides transaction size, price range, and timing, but no new company-specific operational or financial development beyond the Form 4 disclosure.

Albertsons CEO Susan Morris bought 39,409 shares on July 28, 2026, after the stock declined about 26% over six months.

Low to moderate upside bias for sentiment, with limited fundamental follow-through.

The disclosure is fresh and specific, but insider purchases alone rarely reset valuation without accompanying guidance or earnings changes.

Greenwich LifeSciences CEO/CFO Snehal Patel purchased 2,200 shares on July 28-29, 2026, after a 57% six-month decline.

Small, likely transient impact unless paired with other catalysts.

The article includes transaction details and the stock drawdown, but provides no new business or financial information to drive repricing.

CoreWeave CEO Michael Intrator sold about 297,692 shares for roughly $20.5 million on July 28, 2026 under a 10b5-1 plan.

Potential short-term negative sentiment, but likely limited fundamental effect.

The article is specific about size, price range, and 10b5-1 structure, but does not cite new negative company fundamentals.

Snowflake director Benoit Dageville sold 50,000 shares for $14 million on July 29, 2026 under a 10b5-1 plan.

Minimal impact; any effect is likely short-lived sentiment.

The transaction is large and timely, yet the article frames it as 10b5-1 and provides no new operational or guidance change.

Tempus AI CEO/Chairman Eric Lefkofsky sold 250,000 shares for about $10.5 million on July 28, 2026 under a 10b5-1 plan.

Low to moderate near-term sentiment drag; fundamental impact unlikely from this alone.

The article provides transaction size and price range, but no new company-specific news beyond the insider trade disclosure.

Charles Schwab co-chairman Charles Schwab sold about 143,450 shares for roughly $15.17 million on July 28-29, 2026.

Likely limited price impact; any move would be sentiment-related.

The article is detailed on the sale, but does not connect it to new guidance, earnings, or regulatory developments.

Ameriprise CEO James Cracchiolo sold 18,020 shares for about $9.8 million on July 28, 2026, after exercising options earlier that day.

Minimal impact; traders may treat as routine liquidity/compensation activity.

The article includes both the sale and same-day option exercise, which reduces interpretive clarity for directional bets.